Source: Annual Congress 2006 - COPD – inflammation/miscellaneous
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. P. Kolosov, J. M. Perelman (Blagoveschensk, Russian Federation). Methodological approaches to forecasting of cardiorespiratory disturbances in COPD. Eur Respir J 2006; 28: Suppl. 50, 338

Member's Comments

No comment yet.

Related content which might interest you: Methodological issues in evaluating measures of health as outcomes for COPD Source: Eur Respir J 2003; 21: 13S-18S Year: 2003 Methodological issues in therapeutic trials of COPD Source: Eur Respir J 2009; 33: 443-444 Year: 2009 Recognising and addressing the psychosocial and behavioural aspects of COPD and asthma patients Source: Annual Congress 2004 - Psychosocial and behavioural aspects of chronic respiratory diseases Year: 2004 Genome-based risk prediction of asthma and COPD: applicability and psychological issues Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine Year: 2012 Testing a conceptual model of health-related quality of life and clinical variables associations in people with respiratory diseases Source: Annual Congress 2010 - Methods in respiratory epidemiology Year: 2010 Practical quality indicators for asthma management Source: Eur Respir J 2004; 24: Suppl. 48, 85s Year: 2004 The language and psychometrics of dyspnoea in cardiorespiratory diseases Source: Research Seminar 2012 - Dyspnoea: multidimensional and multidisciplinary Year: 2012 Techniques for predicting outcome of therapeutic interventions in respiratory disorders during sleep Source: Annual Congress 2007 - PG21 - Diagnostic and therapeutic aspects of respiratory disorders during sleep Year: 2007 A patient-centered conceptual framework for dyspnea and related functional limitations in COPD Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Real-life assessment of the multidimensional nature of dyspnoea in COPD outpatients Source: Eur Respir J 2016; 47:1668-1679 Year: 2016 Understanding the pathophysiological mechanisms of cardiometabolic complications in obstructive sleep apnoea: towards personalised treatment approaches Source: Eur Respir J, 56 (2) 1902295; 10.1183/13993003.02295-2019 Year: 2020 Measuring and quantifying acute exacerbations of COPD: pitfalls and practicalities Source: Eur Respir J 2014; 43: 662-664 Year: 2014 Comparison of multidimensional assessment systems with regard to risk prediction for exacerbations of COPD Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Methodological impact of two questionnaires on the prevalence of respiratory symptoms Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology Year: 2009 Practical limitations in the implementation of driving guidelines for sleepiness and OSA Source: Sleep and Breathing Conference 2017 Year: 2017 Current challenges in the management of SDB Source: Annual Congress 2012 - Managing the individual challenges of sleep-disordered breathing Year: 2012 What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018 Year: 2018 Exploring the practical applications of a forecast of COPD admissions Source: Eur Respir J 2005; 26: Suppl. 49, 544s Year: 2005 External validation of exacerbation and mortality outcomes of health economic decision models for COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016